CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
PERSONALPROFESSIONALPARTNERS
SUPPORT
en
Trading
Trading
Ways to trade
CFD trading
Rebates for Active Traders
Trading platforms
All platforms 
Web platform
Mobile apps
MT4
TradingView
API documentation
Trading info
Margin Calls
Fraud prevention
Trading tools
Demo trading
CFD calculator
Markets
Markets
Our markets
Shares
Forex
Indices
Commodities
ESG
Cryptocurrencies
Market updates
Market analysis
Pricing
Pricing
Pricing
Charges and fees
Our business model
Markets pricing
Learn
Learn
For trading beginners
Trading essentials
Risk management
Market guides
Demo trading
Investmate app
Glossary
For experienced traders
Trading Strategies
Technical analysis
Market analysis
Trading Psychology
IPO Trading
About
About
About us
Leadership team
Is capital.com safe?
Why Capital.com?
Our history
Our offices
Contact us
Whitepaper
Investor Relations
Media centre
Get help
Help
Client vulnerability
Complaints
Terms and policies
Work for us
Careers
Open platform
PERSONALPROFESSIONALPARTNERS
SUPPORT
en
Open platform

HomeMarketsSharesAbbvie

Trade Abbvie - ABBV CFD

AbbVie Inc. (ABBV) is a research-based pharmaceutical company specialising in the discovery and development of biopharmaceuticals, and small molecule drugs. With a team of 28,000 scientists and researchers across the globe, the company introduces new approaches to treating chronic conditions and life-threatening health issues. AbbVie produces medicines aimed at treating autoimmune diseases; oncology; virology, including hepatitis C and HIV; neurological; and metabolic disorders. The company focuses on developing and delivering innovative solutions for treating the most dangerous and challenging diseases known worldwide. Browse the AbbVie share price (ABBV) chart in real-time and seize an investment opportunity with a world-leading pharmaceutical company at Capital.com.

Latest shares articles

Barrick Gold forecast: Third-party price target
Discover the Barrick Gold (GOLD) price predictions for 2025 and beyond, with analyst price targets and more on Capital.com
14 hours ago
Alibaba price forecast: Third-party price targets
Read our Alibaba price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:43, 30 April 2025
A GameStop store in Portland, Oregon
GameStop stock forecast: Is the latest meme-stock rally over?
Read our GameStop (GME) share price forecast for 2025 and beyond, with insights from third-party analysts and market experts
14:32, 28 April 2025
Nvidia stock forecast: third-party price target
Nvidia stock forecast: third-party price target
Nvidia (NVDA) is down approximately 27.37% since the beginning of 2025 (as of mid-April), and up 26.48% year on year – based on its $98.78 open price on 22 April 2025.
16:04, 25 April 2025

Read our reviews to find out more about us

Read the feedback from our clients, whatever their experience level.
2024-10-22
i********

Very trustworthy and affordable for any size trades

2024-10-21
r******

It is very easy to connect with TradingView but the web interface is also great.

2024-10-15
j********

Easy to use and great support. Been using it for 2 years already and still happy

2024-10-14
D*****

Capital.com is one of the best stock trading platforms I’ve used. The UX and UI on both the mobile app and web platform are outstanding, making it incredibly easy to navigate. They’ve built a vibrant community of traders and investors, and their UAE team really stands out for delivering an exceptional trading experience.

2024-10-08
Y********

Best broker!! they call you to see if you need any help. The app is good and nice better than the rest

2024-10-04
I***** S******

Great app! I requested some features to be added, such as analysis tools, and they delivered. Amazing job! The agents are always helpful and reply quickly. It’s not 5 stars because, at times, some less experienced agents may say it’s impossible to fulfill the request or fix the problem while another agent, like Angel, quickly escalated the issue to the necessary team/person/department and resolved it

2024-10-04
M** S*

This is an excellent platform. The stop loss and take profit work very well; however, when the changes are very fast like at the beginning of the session, the stop loss does not work. If this defect is corrected it will be the perfect platform.

2024-09-30
a***********

-Nice -Easy to use - Beautiful Interface

2024-09-26
D*****

I think I'm new in this trading platform, but I find it affordable and most reliable. To be honest I'm not fully experienced trader, but with very limited knowledge of trading I try learn as much as I can by trying out different platforms see if can make money. My interests growing in you platform, l like news updates you also short videos on YouTube, other propaganda, poster and many more. I will see what happens in the coming months. Thanks capital team.

2024-09-26
J*** F******

Gives you options to start learning how too do it as it gives you a demo option to learn from your mistakes

2024-09-24
P******

Efficiency. When creating the account, it was smooth, efficient from start to finish. Verification of documents also was done the same day, unlike other platforms where you have to wait a day or two.

2024-09-04
O***** P***

From what I'm seeing it's cool Mixing it with trading view it's perfect... I didn't give it 5 star yet cos I still need to use it for some time

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements

4.7
Ratings and Reviews
4.7
Ratings and Reviews
4.6
4.4

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading